Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis

Ying Liu1,2, Sixin Li1,2, Lu Chen3,4

  • 1Department of Psychiatry, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.

Frontiers in Immunology
|February 21, 2024
PubMed
Abstract

Insights

This review analyzes tumor vaccines and the tumor microenvironment, revealing key trends and emerging frontiers in cancer immunotherapy research. Understanding this interplay is vital for developing effective cancer treatments.

Area of Science:

  • Oncology
  • Immunology
  • Bioinformatics

Background:

  • Tumor vaccines are crucial in cancer immunotherapy, but clinical efficacy is limited due to the immunosuppressive tumor microenvironment (TME).
  • The TME's complex interplay with vaccines can lead to low T-cell responses and acquired resistance.
  • Understanding the vaccine-TME correlation is essential for advancing cancer treatment strategies.

Purpose of the Study:

  • To review research on tumor vaccinations and the TME.
  • To investigate the correlation between tumor vaccines and the TME.
  • To identify dominant international research paradigms, historical progression, and emergent patterns.

Main Methods:

  • Bibliometric review of 1420 articles from 1999-2023 from the Web of Science database.
  • Evaluation of publication year, journals, authors, institutions, geography, citations, and keywords.
  • Co-occurrence cluster analysis of top 197 keywords.

Main Results:

  • Publication output increased significantly from 3 to 265 articles annually (1999-2022).
  • Frontiers in Immunology published the most papers (72); Cancer Research had the most citations (2874).
  • The United States dominated research, with the National Cancer Institute and Elizabeth M. Jaffee as highly influential.
  • Five keyword clusters were identified, with "immune therapy," "dendritic cell," "tumor microenvironment," "cancer," and "vaccine" as emerging frontiers.

Conclusions:

  • The review provides insights into current trends, global collaborations, and fundamental knowledge in TME-targeted vaccines.
  • It highlights key research areas and emerging frontiers in the interaction between tumor vaccines and the TME.
  • This understanding is crucial for developing next-generation cancer immunotherapies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K